aTyr Pharma(ATYR) Stock Price Today | Quotes & News

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

ATyr Pharma to Participate in April Investor Conferences
GlobeNewswireApr 3 08:00 ET
Piper Sandler Remains a Buy on ATyr Pharma (ATYR)
TipRanksMar 31 06:56 ET · Ratings
ATyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswireMar 27 16:00 ET
Express News | ATyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ReutersMar 27 16:00 ET
Confident Buy Rating for ATyr Pharma Amidst Promising Phase 3 Study Insights
TipRanksMar 27 07:26 ET · Ratings
Express News | ATyr Pharma Announces the Appointment of Dalia R. Rayes as Head of Commercial, Global Efzofitimod Franchise
ReutersMar 26 08:00 ET

Comments

Jaguar8

Mar 13 04:01

NEWS

$aTyr Pharma (ATYR.US)$
aTyr Pharma Announces Publication Demonstrating Efzofitimod’s Immunomodulatory Activity in Science Translational Medicine
aTyr Pharma has announced a significant publication in Science Translational Medicine validating the mechanism of action of efzofitimod, their lead therapeutic candidate. The research demonstrates efzofitimod's unique anti-inflammatory mechanism targeting macrophages through the neuropilin-2 (NRP2) receptor.
The publication details how efzofitimod,...

4

Jaguar8

Mar 7 07:00

⚫️Watchlist, MARCH 7,2025, Friday. NFA -DrJag8

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you...

48

28

4

Jaguar8

Oct 8, 2024 20:01

NEWS

$aTyr Pharma (ATYR.US)$
aTyr Pharma’s Lead Therapeutic Candidate Efzofitimod for Pulmonary Sarcoidosis to be Featured in Best of CHEST Journals at CHEST 2024 Annual Meeting

2

Jaguar8

Oct 2, 2024 20:03

NEWS

$aTyr Pharma (ATYR.US)$
aTyr Pharma Announces Publication Demonstrating Efficacy of Efzofitimod in Pulmonary Sarcoidosis in the European Respiratory Journal
Post hoc analysis of Phase 1b/2a study demonstrated statistically significant difference in time-to-first-relapse for corticosteroid use in therapeutic (3.0 and 5.0 mg/kg efzofitimod) vs subtherapeutic (1.0 mg/kg efzofitimod and placebo) groups.
54.4% of patients in the subtherapeutic group relapsed following corticosteroid taper, compar...

1

test dummy

Jul 22, 2024 20:11

$aTyr Pharma (ATYR.US)$ prolly gonna get shorted heavily today

ATYR aTyr Pharma

Trade Overview

Capital Trend

News

Comments

Market Insights

Latest News

Investment Course

Discussing

Earnings Season Underway